Standout Papers

Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery 1999 2026 2008 2017 1.7k
  1. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery (2005)
    Bryan T. Hennessy, Debra L. Smith et al. Nature Reviews Drug Discovery
  2. PIK3CA is implicated as an oncogene in ovarian cancer (1999)
    Yiling Lu, Wen-Lin Kuo et al. Nature Genetics
  3. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A (2000)
    Xianjun Fang, Yiling Lu et al. Proceedings of the National Academy of Sciences

Immediate Impact

10 by Nobel laureates 22 from Science/Nature 98 standout
Sub-graph 1 of 18

Citing Papers

PROTAC Prodrug‐Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer
2024 Standout
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
1 intermediate paper

Works of Yiling Lu being referenced

BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
2018
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout

Author Peers

Author Last Decade Papers Cites
Yiling Lu 11410 3422 2905 207 15.3k
Ji Luo 11886 4092 2670 94 15.7k
Morag Park 8488 3951 2350 200 13.2k
Wenyi Wei 12924 5786 2805 236 17.0k
Fredrik Pontén 8178 3598 2768 269 13.9k
Linda Z. Penn 10170 3917 4586 137 14.5k
Daniel E. Johnson 8289 4222 2198 131 13.2k
Nicholas Mitsiades 9945 4460 2356 172 15.1k
Jane B. Trepel 11620 4354 3163 288 17.3k
Haian Fu 13357 2520 1517 216 17.1k
Ju‐Seog Lee 7866 3639 3894 212 13.2k

All Works

Loading papers...

Rankless by CCL
2026